Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy

Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard of care in metastatic and locally advanced BRAF V600 mutated melanoma. An immune-mediated mechanism has been advocated in the pathogenesis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Consoli, Francesca, Manganoni, Ausilia Maria, Grisanti, Salvatore, Petrelli, Fausto, Venturini, Marina, Rangoni, Giovanni, Guarneri, Francesco, Incardona, Paolo, Vermi, William, Calzavara Pinton, Pier Giacomo, Berruti, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445428/
https://www.ncbi.nlm.nih.gov/pubmed/30939167
http://dx.doi.org/10.1371/journal.pone.0214884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445428/
https://www.ncbi.nlm.nih.gov/pubmed/30939167
http://dx.doi.org/10.1371/journal.pone.0214884

Ejemplares similares